Share
Share
Portal hypertension is a complication of children with biliary atresia. It results from progression of liver scarring (fibrosis) and can lead to gastrointestinal bleeding and accumulation of fluid in the abdomen (also known as ascites). In this study, investigations from the Childhood Liver Disease Research Network analyzed the blood of patients to identify protein that increase in children with portal hypertension. Investigators analyzed over 1,000 proteins using an assay known as proteomics. Among the proteins that increased in babies with portal hypertension they found that semaphorin 6B (SEMA6B) alone and three other protein combinations (SEMA6B+SFRP3, SEMA6B+COMMD7, and VCAM1+BMX) had high accuracy to identify portal hypertension. Analyzing liver biopsies, the new protein biomarkers showed increased expression in liver vascular cells (endothelial cells), bile duct epithelium (cholangiocytes), and immune cells within portal triads.
Conclusion
Large-scale proteomics identified SEMA6B, SFRP3, COMMD7, BMX, and VCAM1 as biomarkers highly associated with clinical portal hypertension in children with biliary atresia. The expression of the biomarkers in liver epithelial, endothelial, and immune cells support their potential role in the mechanisms that cause portal hypertension.
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal […]
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen […]
Arbor Research Collaborative for Health (Arbor Research) is proud to announce that its wholly-owned, small-business subsidiary, Arbor Research LLC, received its first competitive prime contract award. The award expands the organization’s 25-year history doing mission-impactful work in chronic disease and beyond. Arbor Research was awarded the National Cancer Institute (NCI) Center for Global Health (CGH) […]
Arbor Research Collaborative for Health, a Michigan-based 501(c)3 nonprofit corporation, is proud to announce the award of the General Services Administration (GSA) Multiple Award Schedule contract to its subsidiary, Arbor Research LLC under SINs 541611 and 541715. Arbor Research LLC qualifies as a small business under the associated NAICS codes and will seek additional SINs […]